Prognostic value of circulating tumor cells in metastatic breast cancer: a systemic review and meta-analysis (Q38564112)

4 September 2017

0 references

1 reference

title

Prognostic value of circulating tumor cells in metastatic breast cancer: a systemic review and meta-analysis (English)

1 reference

4 September 2017

main subject

metastatic breast cancer

1 reference

Q Lv

1

1 reference

4 September 2017

L Gong

2

1 reference

4 September 2017

T Zhang

3

1 reference

4 September 2017

J Ye

4

1 reference

4 September 2017

L Chai

5

1 reference

4 September 2017

C Ni

6

1 reference

4 September 2017

Y Mao

7

1 reference

4 September 2017

language of work or name

1 reference

11 August 2015

1 reference

Clinical and Translational Oncology

4 September 2017

published in

1 reference

4 September 2017

volume

18

1 reference

4 September 2017

issue

3

1 reference

4 September 2017

page(s)

322-330

1 reference

Meta-analysis of the prognostic value of circulating tumor cells in breast cancer

4 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1372-1

Circulating tumor cells in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1372-1

Detection and isolation of circulating tumor cells: principles and methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1372-1

Circulating tumor cells predict progression-free and overall survival in Chinese patients with metastatic breast cancer, HER2-positive or triple-negative (CBCSG004): a multicenter, double-blind, prospective trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1372-1

Circulating tumor cells in immunohistochemical subtypes of metastatic breast cancer: lack of prediction in HER2-positive disease treated with targeted therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1372-1

The prognostic role of circulating tumor cells (CTCs) detected by RT-PCR in breast cancer: a meta-analysis of published literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1372-1

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1372-1

Detection, clinical relevance and specific biological properties of disseminating tumour cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1372-1

Significance of Circulating Tumor Cells Detected by the CellSearch System in Patients with Metastatic Breast Colorectal and Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1372-1

Circulating tumor cells versus imaging--predicting overall survival in metastatic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1372-1

Evaluation of circulating tumor cells in patients with breast cancer: multi-institutional clinical trial in Japan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1372-1

Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1372-1

Circulating tumor cells: a useful predictor of treatment efficacy in metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1372-1

Circulating tumor cells and bone metastases as detected by FDG-PET/CT in patients with metastatic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1372-1

Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1372-1

Detection of circulating tumor cells in peripheral blood of heavily treated metastatic breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1372-1

Relationship between lymphocytopenia and circulating tumor cells as prognostic factors for overall survival in metastatic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1372-1

Prognostic value of HER2-positive circulating tumor cells in patients with metastatic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1372-1

Prognostic impact of circulating tumor cells assessed with the CellSearch System™ and AdnaTest Breast™ in metastatic breast cancer patients: the DETECT study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1372-1

Detection of circulating tumor cells in blood of metastatic breast cancer patients using a combination of cytokeratin and EpCAM antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1372-1

Circulating tumor cells in HER2-positive metastatic breast cancer patients: a valuable prognostic and predictive biomarker

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1372-1

The prognostic impact of circulating tumor cells in subtypes of metastatic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1372-1

Circulating tumor cells and response to chemotherapy in metastatic breast cancer: SWOG S0500

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1372-1

Circulating tumor cells following first chemotherapy cycle: an early and strong predictor of outcome in patients with metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1372-1

HER2-positive circulating tumor cells in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1372-1

Prognostic value of circulating tumor cells according to immunohistochemically defined molecular subtypes in advanced breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1372-1

Analysis of circulating tumor cells in patients with triple negative breast cancer during preoperative chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1372-1

Detection and characterization of putative metastatic precursor cells in cancer patients

21 January 2018

1 reference

12 December 2020

Circulating tumor cells in metastatic inflammatory breast cancer

1 reference

12 December 2020

Prognostic significance of circulating tumor cells and serum CA15-3 levels in metastatic breast cancer, single center experience, preliminary results

1 reference

12 December 2020

Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival

1 reference

12 December 2020

Prognosis of women with stage IV breast cancer depends on detection of circulating tumor cells rather than disseminated tumor cells

1 reference

12 December 2020

Detection of circulating tumor cells in breast cancer patients: prognostic predictive role.

1 reference

12 December 2020

High independent prognostic and predictive value of circulating tumor cells compared with serum tumor markers in a large prospective trial in first-line chemotherapy for metastatic breast cancer patients

1 reference

12 December 2020

Changing levels of circulating tumor cells in monitoring chemotherapy response in patients with metastatic breast cancer

1 reference

12 December 2020

Circulating tumor cells as predictors of prognosis in metastatic breast cancer: clinical application outside a clinical trial

1 reference

12 December 2020

The influence of removal of primary tumor on incidence and phenotype of circulating tumor cells in primary breast cancer

1 reference

12 December 2020

Circulating tumor cells in metastatic breast cancer: biologic staging beyond tumor burden

1 reference

12 December 2020

10.1007/S12094-015-1372-1

Identifiers

DOI

1 reference

4 September 2017

1 reference